Howe & Rusling’s Cellcom Israel, Ltd. CEL Stock Holding History

Howe & Rusling’s Portfolio CEL Stock Details CEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,000	Closed	-$12K	–	891
2020 Q2	$12K	Hold	3,000	–	–	﹤0.01%	417
2020 Q1	$9K	Buy	+3,000	New	+$9.69K	﹤0.01%	443

Other funds holding CEL

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MetLife New York $12.3M AUM 29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Howe & Rusling's CEL Position: Q3 2020 in Review

Howe & Rusling sold out of Cellcom Israel, Ltd. (CEL) in Q3 2020, closing a stake of 3,000 shares — an estimated $12K sold.

Howe & Rusling first reported a position in CEL in Q1 2020 and held it in 2 quarters. The position peaked at $12K in Q2 2020. 34 funds tracked by Wall St. Rank hold CEL as of Q3 2020.

Howe & Rusling reported no remaining Cellcom Israel, Ltd. position as of Q3 2020 after selling out during the quarter.
Howe & Rusling sold 3,000 Cellcom Israel, Ltd. shares in Q3 2020, an estimated $12K.
Howe & Rusling first reported a position in Cellcom Israel, Ltd. in Q1 2020 and held it in 2 quarters.
Howe & Rusling's Cellcom Israel, Ltd. position peaked at $12K in Q2 2020.
34 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q3 2020.

Based on Howe & Rusling's 13F filing for Q3 2020, filed 6 Nov 2020.